Characterization of protein-protein interactions by isothermal titration calorimetry.

[1]  E. Freire,et al.  Direct measurement of protein binding energetics by isothermal titration calorimetry. , 2001, Current Opinion in Structural Biology.

[2]  T. Arakawa,et al.  Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. , 1996, Biochemistry.

[3]  A. Velázquez‐Campoy,et al.  Thermodynamic rules for the design of high affinity HIV-1 protease inhibitors with adaptability to mutations and high selectivity towards unwanted targets. , 2004, The international journal of biochemistry & cell biology.

[4]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[5]  Ashutosh Tripathy,et al.  Effects of molecular crowding by saccharides on α‐chymotrypsin dimerization , 2002, Protein science : a publication of the Protein Society.

[6]  T. Lundqvist,et al.  Crystal Structure of an Antagonist Mutant of Human Growth Hormone, G120R, in Complex with Its Receptor at 2.9 Å Resolution* , 1996, The Journal of Biological Chemistry.

[7]  K. P. Murphy,et al.  The energetics of phosphate binding to a protein complex , 2000, Protein science : a publication of the Protein Society.

[8]  K. P. Murphy,et al.  Dissecting the energetics of a protein-protein interaction: the binding of ovomucoid third domain to elastase. , 1997, Journal of molecular biology.

[9]  V. Hilser,et al.  The heat capacity of proteins , 1995, Proteins.

[10]  A. Velázquez‐Campoy,et al.  Incorporating target heterogeneity in drug design , 2001, Journal of cellular biochemistry. Supplement.

[11]  M. Doyle,et al.  Tight ligand binding affinities determined from thermodynamic linkage to temperature by titration calorimetry. , 1998, Methods in enzymology.

[12]  K. Christopher Garcia,et al.  The Structure of Interleukin-2 Complexed with Its Alpha Receptor , 2005, Science.

[13]  J F Brandts,et al.  Rapid measurement of binding constants and heats of binding using a new titration calorimeter. , 1989, Analytical biochemistry.

[14]  E. Freire,et al.  Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin. , 1995, Journal of molecular biology.

[15]  J. Wyman,et al.  Binding and Linkage: Functional Chemistry of Biological Macromolecules , 1990 .

[16]  A. Velázquez‐Campoy,et al.  The binding energetics of first- and second-generation HIV-1 protease inhibitors: implications for drug design. , 2001, Archives of biochemistry and biophysics.

[17]  K. P. Murphy,et al.  Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. , 1994, Biochemistry.

[18]  R. Biltonen,et al.  [14] Microcalorimetry for biological chemistry: Experimental design, data analysis, and interpretation , 1979 .

[19]  C. Humblet,et al.  Analysis of the binding of hydroxamic acid and carboxylic acid inhibitors to the stromelysin-1 (matrix metalloproteinase-3) catalytic domain by isothermal titration calorimetry. , 1999, Biochemistry.

[20]  G. Holdgate,et al.  Isothermal titration calorimetry in drug discovery. , 2001, Progress in medicinal chemistry.

[21]  A. Velázquez‐Campoy,et al.  Thermodynamic dissection of the binding energetics of KNI‐272, a potent HIV‐1 protease inhibitor , 2000, Protein science : a publication of the Protein Society.

[22]  A. Velázquez‐Campoy,et al.  HIV-1 protease inhibitors: enthalpic versus entropic optimization of the binding affinity. , 2000, Biochemistry.

[23]  J. Sturtevant,et al.  Calorimetric investigation of inhibitor binding to rabbit muscle aldolase. , 1971, Biochemistry.

[24]  A. Velázquez‐Campoy,et al.  Thermodynamic basis of resistance to HIV-1 protease inhibition: calorimetric analysis of the V82F/I84V active site resistant mutant. , 2000, Biochemistry.

[25]  E. Freire,et al.  ITC in the post-genomic era...? Priceless. , 2005, Biophysical chemistry.

[26]  H. F. Fisher,et al.  Theoretical aspects of isothermal titration calorimetry. , 1998, Methods in enzymology.

[27]  A. Kossiakoff,et al.  Site2 binding energetics of the regulatory step of growth hormone–induced receptor homodimerization , 2003, Protein science : a publication of the Protein Society.

[28]  B. Sigurskjold,et al.  Exact analysis of competition ligand binding by displacement isothermal titration calorimetry. , 2000, Analytical biochemistry.

[29]  M. Doyle,et al.  Characterization of binding interactions by isothermal titration calorimetry. , 1997, Current opinion in biotechnology.

[30]  E. Freire,et al.  Adaptive inhibitors of the HIV-1 protease. , 2005, Progress in biophysics and molecular biology.

[31]  Z. Zhang,et al.  Low-affinity binding determined by titration calorimetry using a high-affinity coupling ligand: a thermodynamic study of ligand binding to protein tyrosine phosphatase 1B. , 1998, Analytical biochemistry.

[32]  K. P. Murphy,et al.  Thermodynamics of structural stability and cooperative folding behavior in proteins. , 1992, Advances in protein chemistry.

[33]  A. Velázquez‐Campoy,et al.  Isothermal titration calorimetry , 1990 .

[34]  E. Freire,et al.  Overcoming Roadblocks in Lead Optimization: A Thermodynamic Perspective , 2006, Chemical biology & drug design.

[35]  M. Botchan,et al.  The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. , 2004, Genes & development.

[36]  A. Velázquez‐Campoy,et al.  Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design. , 2003, Current drug targets. Infectious disorders.

[37]  W A Hendrickson,et al.  Energetics of the HIV gp120-CD4 binding reaction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Bosshard,et al.  Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition , 1999, Journal of molecular recognition : JMR.

[39]  P. Reinemer,et al.  Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface , 1999, Cell.

[40]  Peter D. Kwong,et al.  HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites , 2002, Nature.